Sales & Marketing News | pharmaphorum

News

PM Society announces new Chair for 2024

The PM Society has appointed Dom Marchant, Chief Creative Officer at OPEN Health, as Chair, to succeed co-chairs Caroline Benson of Cuttsy + Cuttsy and Colin Williams from Astellas.

News

Novo Nordisk sets aside $6bn to boost production capacity

Novo Nordisk is leaving nothing to chance when it comes to claiming a stake in the burgeoning market for diabetes and obesity therapies, announcing a plan to spend a whopp

News

Takeda gets okay in US for rare blood disorder drug

Patients in the US with ultra-rare blood clotting disorder congenital thrombotic thrombocytopenic purpura (cTTP) have an FDA-approved therapy for the first time, after Tak

News

First chikungunya vaccine approved by FDA

Valneva has claimed the accolade of becoming the first drugmaker to win FDA approval for a vaccine for chikungunya virus, a potentially life-threatening mosquito-borne dis

News

AstraZeneca builds in obesity with $2bn+ Eccogene deal

AstraZeneca headlined its third-quarter earnings update with news of a $185 million upfront licensing deal with Chinese biotech Eccogene for an orally active GLP-1 agonist

News

Lilly gets FDA okay for tirzepatide as obesity therapy

Novo Nordisk is finally facing some major competition to its obesity franchise juggernaut, now that Eli Lilly’s rival therapy tirzepatide has been approved by the FDA as a

PM Society announces new Chair for 2024

Novo Nordisk sets aside $6bn to boost production capacity

Takeda gets okay in US for rare blood disorder drug

First chikungunya vaccine approved by FDA

AstraZeneca builds in obesity with $2bn+ Eccogene deal

Lilly gets FDA okay for tirzepatide as obesity therapy

LSX2026: Addressing adult eye cancer, with Roi Raz

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks